COURTNEY CASE: Open Payments
NPI 1831979236 · TROY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $57 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| PFIZER INC. | 1 | $34 |
| Novo Nordisk Inc | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $13 |
Products named: LEQVIO, ELIQUIS, Wegovy, Kerendia, FARXIGA, JARDIANCE.
Industry payments across PA — which companies pay providers there.
